How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q3 2022?

114 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q3 2022. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 64,074,481
Share change: -66,143
Total reported value: $649,741,089
Put/Call ratio: 59%
Price per share: $10.14
Number of holders: 114
Value change: +$1,849,322
Number of buys: 65
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	26%	13,419,226	$121,578,000	—	30 Jun 2022	13F
Weiss Asset Management LP	3/4/5 13F	10%+ Owner · Company	12% from 13F	7,457,060	$76,733,147	—	19 Sep 2022	3/4/5 13F
Madison Avenue Partners, LP	13F	Company	14%	7,269,584	$65,862,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	13%	6,544,806	$59,295,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	9.8%	5,022,740	$45,505,000	—	30 Jun 2022	13F
Park West Asset Management LLC	13F	Company	6.2%	3,173,254	$28,750,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	5.2%	2,698,333	$24,447,000	—	30 Jun 2022	13F
Woodline Partners LP	13F	Company	4.4%	2,243,473	$20,326,000	—	30 Jun 2022	13F
Newtyn Management, LLC	13F	Company	4%	2,037,825	$18,463,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	2.9%	1,495,046	$13,545,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	2.7%	1,380,397	$12,507,000	—	30 Jun 2022	13F
ORBIMED ADVISORS LLC	13F	Company	2.7%	1,370,250	$12,414,000	—	30 Jun 2022	13F
Chescapmanager LLC	13F	Company	2.3%	1,160,503	$10,514,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2%	1,027,664	$9,310,000	—	30 Jun 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.7%	859,606	$7,788,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.3%	675,625	$6,121,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	1.2%	595,234	$5,393,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	583,029	$5,282,000	—	30 Jun 2022	13F
NORGES BANK	13F	Company	1.1%	545,427	$4,941,569	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.98%	503,477	$4,562,000	—	30 Jun 2022	13F
Frank Pasqualone	3/4/5	SVP, CHIEF BUSINESS OFFICER	— class O/S missing	429,783	$4,422,467	—	19 Nov 2021	3/4/5
Kenneth R. Pitzer	3/4/5	SVP, PROD STRAT & COMM PLNG	— class O/S missing	380,123	$3,911,466	—	18 Feb 2022	3/4/5
MORGAN STANLEY	13F	Company	0.77%	393,566	$3,565,000	—	30 Jun 2022	13F
Philip D. Worboys	3/4/5	SVP, RESEARCH & TRANSL SCIENCE	— class O/S missing	330,752	$3,403,438	—	19 Nov 2021	3/4/5
Bradford J. Shafer	3/4/5	EVP, Gen. Counsel, Secretary	— class O/S missing	277,831	$2,858,881	—	20 Aug 2021	3/4/5
Vijay Sabesan	3/4/5	SVP, TECHNICAL OPERATIONS	— class O/S missing	235,524	$2,423,542	—	19 Nov 2021	3/4/5
PICTET ASSET MANAGEMENT SA	13F	Company	0.51%	261,427	$2,369,000	—	30 Jun 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.49%	252,845	$2,291,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.47%	240,162	$2,176,000	—	30 Jun 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	0.42%	217,477	$1,953,000	—	30 Jun 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.42%	214,712	$1,946,000	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.4%	207,355	$1,879,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.35%	181,915	$1,648,000	—	30 Jun 2022	13F
First Pacific Advisors, LP	13F	Company	0.34%	176,539	$1,599,000	—	30 Jun 2022	13F
PDT Partners, LLC	13F	Company	0.3%	156,131	$1,415,000	—	30 Jun 2022	13F
AXA S.A.	13F	Company	0.3%	153,425	$1,390,031	—	30 Jun 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.29%	147,468	$1,336,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	0.25%	130,642	$1,184,000	—	30 Jun 2022	13F
Ann Brady	3/4/5	PRESIDENT, TBIL	— class O/S missing	110,319	$1,135,183	—	18 Feb 2022	3/4/5
GSA CAPITAL PARTNERS LLP	13F	Company	0.22%	114,646	$1,039,000	—	30 Jun 2022	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.21%	108,650	$984,369	—	30 Jun 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.21%	105,900	$959,000	—	30 Jun 2022	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.2%	104,008	$943,000	—	30 Jun 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.2%	103,280	$936,000	—	30 Jun 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.2%	103,049	$934,000	—	30 Jun 2022	13F
Brandywine Global Investment Management, LLC	13F	Company	0.19%	96,800	$877,000	—	30 Jun 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.18%	90,569	$821,000	—	30 Jun 2022	13F
William D. Young	3/4/5	Director	— mixed-class rows	106,010 mixed-class rows	$802,723	—	26 Apr 2022	3/4/5
JANE STREET GROUP, LLC	13F	Company	0.17%	86,733	$786,000	—	30 Jun 2022	13F
Walleye Capital LLC	13F	Company	0.16%	82,758	$750,000	—	30 Jun 2022	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q3 2022

As of 30 Sep 2022, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,074,481 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Weiss Asset Management LP, Madison Avenue Partners, LP, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Newtyn Management, LLC, Park West Asset Management LLC, D. E. Shaw & Co., Inc., and STATE STREET CORP. This page lists 115 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

106

Q3 2022 holders

114

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.